Jasper Therapeutics Inc (JSPR)
22.98
+0.14
(+0.59%)
USD |
NASDAQ |
May 17, 16:00
22.98
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Total Assets (Quarterly): 125.96M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 125.96M |
| December 31, 2023 | 94.89M |
| September 30, 2023 | 110.40M |
| June 30, 2023 | 124.17M |
| March 31, 2023 | 138.76M |
| December 31, 2022 | 48.36M |
| Date | Value |
|---|---|
| September 30, 2022 | 59.11M |
| June 30, 2022 | 70.37M |
| March 31, 2022 | 80.55M |
| December 31, 2021 | 93.65M |
| September 30, 2021 | 107.21M |
| December 31, 2020 | 23.36M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.36M
Minimum
Dec 2020
138.76M
Maximum
Mar 2023
89.73M
Average
94.27M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.73M |
| Shareholders Equity (Quarterly) | 113.23M |